The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulations

New regulations regarding elemental impurities in pharmaceuticals will be implemented in January 2018 and the guidelines include the use of inductively coupled plasma optical emission spectroscopy (ICP-OES) and inductively coupled plasma mass spectrometry (ICP-MS). In this work, a method using each...

Full description

Bibliographic Details
Main Authors: Samar Thiab, Mark Wainwright, Philip Riby
Format: Article
Language:English
Published: University of Huddersfield Press 2017-12-01
Series:British Journal of Pharmacy
Subjects:
Online Access:https://www.bjpharm.org.uk/article/id/41/
_version_ 1797821678350237696
author Samar Thiab
Mark Wainwright
Philip Riby
author_facet Samar Thiab
Mark Wainwright
Philip Riby
author_sort Samar Thiab
collection DOAJ
description New regulations regarding elemental impurities in pharmaceuticals will be implemented in January 2018 and the guidelines include the use of inductively coupled plasma optical emission spectroscopy (ICP-OES) and inductively coupled plasma mass spectrometry (ICP-MS). In this work, a method using each instrument was developed for the analysis of arsenic (As), cadmium (Cd), mercury (Hg), lead (Pb), cobalt (Co), nickel (Ni) and vanadium (V) and validated to meet the international conference of harmonisation (ICH Q3D) guidelines. Liquid and solid samples were prepared using microwave assisted acid digestion method that was developed using reverse aqua regia. The results obtained from the validation showed good linearity (R2>0.995) with low limits of detections (LODs) and limits of quantifications (LOQs). The percentage recoveries for both the standard reference material (SRM) and the spiked samples were between 95-105% with relative standard deviation (RSD) of less than 5. Cold symptoms relief products were purchased and analysed. Levels of Pb and Cd in certain products were found to exceed the permitted daily exposure limit (PDE) when the maximum dose was taken.
first_indexed 2024-03-13T09:57:19Z
format Article
id doaj.art-1e5fa5189cce4d458379f4d8cd5570c5
institution Directory Open Access Journal
issn 2058-8356
language English
last_indexed 2024-03-13T09:57:19Z
publishDate 2017-12-01
publisher University of Huddersfield Press
record_format Article
series British Journal of Pharmacy
spelling doaj.art-1e5fa5189cce4d458379f4d8cd5570c52023-05-23T14:49:08ZengUniversity of Huddersfield PressBritish Journal of Pharmacy2058-83562017-12-012210.5920/bjpharm.2017.12The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulationsSamar ThiabMark WainwrightPhilip RibyNew regulations regarding elemental impurities in pharmaceuticals will be implemented in January 2018 and the guidelines include the use of inductively coupled plasma optical emission spectroscopy (ICP-OES) and inductively coupled plasma mass spectrometry (ICP-MS). In this work, a method using each instrument was developed for the analysis of arsenic (As), cadmium (Cd), mercury (Hg), lead (Pb), cobalt (Co), nickel (Ni) and vanadium (V) and validated to meet the international conference of harmonisation (ICH Q3D) guidelines. Liquid and solid samples were prepared using microwave assisted acid digestion method that was developed using reverse aqua regia. The results obtained from the validation showed good linearity (R2>0.995) with low limits of detections (LODs) and limits of quantifications (LOQs). The percentage recoveries for both the standard reference material (SRM) and the spiked samples were between 95-105% with relative standard deviation (RSD) of less than 5. Cold symptoms relief products were purchased and analysed. Levels of Pb and Cd in certain products were found to exceed the permitted daily exposure limit (PDE) when the maximum dose was taken.https://www.bjpharm.org.uk/article/id/41/pharmacyicp-msicp-oeselemental impuritiesapsmedicine
spellingShingle Samar Thiab
Mark Wainwright
Philip Riby
The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulations
British Journal of Pharmacy
pharmacy
icp-ms
icp-oes
elemental impurities
aps
medicine
title The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulations
title_full The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulations
title_fullStr The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulations
title_full_unstemmed The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulations
title_short The development of analytical procedures using ICP-OES and ICP-MS for the analysis of trace metals in pharmaceutical formulations
title_sort development of analytical procedures using icp oes and icp ms for the analysis of trace metals in pharmaceutical formulations
topic pharmacy
icp-ms
icp-oes
elemental impurities
aps
medicine
url https://www.bjpharm.org.uk/article/id/41/
work_keys_str_mv AT samarthiab thedevelopmentofanalyticalproceduresusingicpoesandicpmsfortheanalysisoftracemetalsinpharmaceuticalformulations
AT markwainwright thedevelopmentofanalyticalproceduresusingicpoesandicpmsfortheanalysisoftracemetalsinpharmaceuticalformulations
AT philipriby thedevelopmentofanalyticalproceduresusingicpoesandicpmsfortheanalysisoftracemetalsinpharmaceuticalformulations
AT samarthiab developmentofanalyticalproceduresusingicpoesandicpmsfortheanalysisoftracemetalsinpharmaceuticalformulations
AT markwainwright developmentofanalyticalproceduresusingicpoesandicpmsfortheanalysisoftracemetalsinpharmaceuticalformulations
AT philipriby developmentofanalyticalproceduresusingicpoesandicpmsfortheanalysisoftracemetalsinpharmaceuticalformulations